Investigational Drug Details
| Drug ID: | D398 |
| Drug Name: | Thiothixene |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB01623 |
| DrugBank Description: | A thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics. |
| PubChem ID: | 941651 |
| CasNo: | 3313-26-6 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1 |
| Structure: |
|
| InChiKey: | GFBKORZTTCHDGY-UWVJOHFNSA-N |
| Molecular Weight: | 443.625 |
| DrugBank Targets: | Dopamine D2 receptor; Dopamine D1 receptor; 5-hydroxytryptamine receptor 2A |
| DrugBank MoA: | Thiothixene acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects). |
| DrugBank Pharmacology: | Thiothixene is an antipsychotic of the thioxanthene series. Navane possesses certain chemical and pharmacological similarities to the piperazine phenothiazines and differences from the aliphatic group of phenothiazines. Although widely used in the treatment of schizophrenia for several decades, thiothixene is seldom used today in favor of atypical antipsychotics such as risperidone. |
| DrugBank Indication: | For the management of schizophrenia. |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|